Abstract:In the presented literature review, we conducted a meta-analysis of the effectiveness of 3 surgical treatment options for patients with pharmacoresistant temporal lobe epilepsy. Despite the widespread use of the new type of antiepileptic drugs, there are still more than 30 % of patients with epilepsy, which developed into pharmacoresistant epilepsy. Wiebe S. et al. conducted a randomized control trail (RCT) and proved that the one-year recovery rate of patients with temporal lobe epilepsy with surgical treatment was significantly higher than that with medication treatment (58 % vs. 8 %). This study proves that surgery can be effective in treating pharmacoresistant temporal lobe epilepsy [10]. Additionally, it was found that the surgically treated patients at 6 months postoperative follow-up achieved a positive minimum clinically significant change (MCID) in quality of life in epilepsy (QOLIE)-89, compared to those in the medical group (56,0 % vs. 11,0 %, p < 0,001), while 62.0 % of the surgical group achieved a positive MCID value on QOLIE-31 (p < 0,001) compared to 17,0 % in the medical group.

Meta-analysis of surgical methods for pharmacoresistant temporal lobe epilepsy